January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
Market insights predict, the cartilage repair industry is expected to grow from USD 1.51 billion in 2024 to USD 7.32 billion by 2034, driven by a CAGR of 17.14%. The cartilage repair market is growing due to the rising geriatric population. North America’s dominance can be attributed to the rising cases of injuries in adults....
April 21, 2026
According to forecasts, the global drug-induced dyskinesia market will grow from USD 418 million in 2024 to USD 627.5 million by 2034, with an expected CAGR of 4.34%. The market is growing due to the rising prevalence of Parkinsons disease and increased long-term use of dopaminergic therapies. North America dominated the market due to the rising de...
April 21, 2026
The peptide-based weight loss medication market is expanding due to a growing health-conscious population as well as rising muscle-preserving weight loss medications. North America led the market due to the presence of a well-developed healthcare sector....
April 21, 2026
Projections indicate that, biological therapies industry is projected to rise from USD 458.47 billion in 2024 to USD 1107.66 billion by 2034, reflecting a CAGR of 9.35% over the next decade. The biological therapies market is rising due to the rising demand for personalized medicine. North America’s dominance can be attributed to the rising i...
April 21, 2026
According to market projections, the pain management drugs sector is expected to grow from USD 84.1 billion in 2024 to USD 126.17 billion by 2034, reflecting a CAGR of 4.14%. The rising prevalence of chronic pain and growing research and development activities drive the global market. North America dominated the market due to the availability of st...
April 21, 2026
Based on market forecasts, the U.S. osteoarthritis therapeutics market, projected at USD 3.27 billion in 2024, is expected to reach USD 6.46 billion by 2034, growing at a CAGR of 7.14% over the forecast period. The severe disease burden, the limited efficacy of current therapies, and the demand for innovative solutions raise the importance of osteo...
April 21, 2026
Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of the market in the near future. North America led the global market owing to the high prevalence of os...
April 21, 2026
Market insights predict, the U.S. anti-aging industry is expected to grow from USD 20.21 billion in 2024 to USD 39.6 billion by 2034, driven by a CAGR of 6.95%. The U.S. anti-aging market is expanding due to growing demand for regenerative medicines as well as rising skincare awareness....
April 21, 2026
Projections indicate that, the global TCR therapy market will increase from USD 362 million in 2024 to USD 1264.73 million by 2034, experiencing a CAGR of 13.44% over the next 10 years. The regulatory approvals, promising clinical trials, clinical validation, and effectiveness against solid tumors drive the need for T-cell receptor therapy in cance...
April 21, 2026
Projections indicate that, dialectical behavior therapy industry is projected to rise from USD 1.31 billion in 2025 to USD 3.29 billion by 2035, reflecting a CAGR of 9.67% over the next decade. The dialectical behavior therapy market is growing due to the rise in remote patient monitoring approaches. North America’s dominance can be attribute...